Everand Logo

Welcome to Everand!

  • STAT

    STAT+: Pharmalittle: SEC probes Cassava over Alzheimer’s drug results; Teva takes pharma in a new direction with a bond sale

    The SEC is investigating claims Cassava Sciences manipulated research results of its experimental Alzheimer’s drug.
    by Ed Silverman Nov 18, 2021 1 minute
    Source: Alex Hogan/STAT

    Rise and shine, everyone. Another busy day is on the way. We can tell because the hum of life is seen and

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min readChemistry
    STAT+: Pharmalittle: We’re Reading About Fake Studies, AbbVie Investing In Psychedelics, And More
    Fake studies have flooded publishers of top scientific journals,. leading to thousands of retractions and millions of dollars in lost revenue.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
    When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
    STAT1 min read
    Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
    To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

    Related Books & Audiobooks